Yana Mukhamedshina

Dr. Yana Mukhamedshina

Kazan (Volga region) Federal University
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2024 in Cells
Verified
Journal Article
Open access
PDF file
TATatyana Ageeva
Tatyana Ageeva
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Yana MukhamedshinaYana Mukhamedshina
Yana Mukhamedshina
Spinal cord injury (SCI) leads to significant functional impairments below the level of the injury, and astrocytes play a crucial role in the pathophysiology of SCI. Astrocytes undergo changes and form a glial scar after SCI, which has traditionally been viewed as a barrier to axonal regeneration and functional recovery. Astrocytes activate intracellular signaling pathways, including nuclear factor κB (NF-κB) and Janus kinase-signal transducers and activators of transcription (JAK/STAT), in response to external stimuli. NF-κB and STAT3 are transcription factors that play a pivotal role in initiating gene expression related to astrogliosis. The JAK/STAT signaling pathway is essential for managing secondary damage and facilitating recovery processes post-SCI: inflammation, glial scar formation, and astrocyte survival. NF-κB activation in astrocytes leads to the production of pro-inflammatory factors by astrocytes. NF-κB and STAT3 signaling pathways are interconnected: NF-κB activation in astrocytes leads to the release of interleukin-6 (IL-6), which interacts with the IL-6 receptor and initiates STAT3 activation. By modulating astrocyte responses, these pathways offer promising avenues for enhancing recovery outcomes, illustrating the crucial need for further investigation into their mechanisms and therapeutic applications in SCI treatment.

27 August 2019 in Frontiers in Systems Neuroscience
Verified
Journal Article
Open access
PDF file
EAElvira Akhmetzyanova
Elvira Akhmetzyanova
KKKonstantin Kletenkov
Konstantin Kletenkov
Yana MukhamedshinaYana Mukhamedshina
Yana Mukhamedshina
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Microglial cells, which are highly plastic, immediately respond to any change in the microenvironment by becoming activated and shifting the phenotype toward neurotoxicity or neuroprotection. The polarization of microglia/macrophages after spinal cord injury (SCI) seems to be a dynamic process and can change depending on the microenvironment, stage, course, and severity of the posttraumatic process. Effective methods to modulate microglia toward a neuroprotective phenotype in order to stimulate neuroregeneration are actively sought for. In this context, available approaches that can selectively impact the polarization of microglia/macrophages regulate synthesis of trophic factors and cytokines/chemokines in them, and their phagocytic function and effects on the course and outcome of SCI are discussed in this review.

1 January 2019 in Neural Regeneration Research
Verified
Journal Article
Open access
Yana MukhamedshinaYana Mukhamedshina
Yana Mukhamedshina
OGOlgaA Gracheva
OlgaA Gracheva
DMDinaM Mukhutdinova
DinaM Mukhutdinova
YCYuriiA Chelyshev
YuriiA Chelyshev
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Cell-based technologies are used as a therapeutic strategy in spinal cord injury (SCI). Mesenchymal stem cells (MSCs), which secrete various neurotrophic factors and cytokines, have immunomodulatory, anti-apoptotic and anti-inflammatory effects, modulate reactivity/phenotype of astrocytes and the microglia, thereby promoting neuroregeneration seem to be the most promising. The therapeutic effect of MSCs is due to a paracrine mechanism of their action, therefore the survival of MSCs and their secretory phenotype is of particular importance. Nevertheless, these data are not always reported in efficacy studies of MSC therapy in SCI. Here, we provide a review with summaries of preclinical trials data evaluating the efficacy of MSCs in animal models of SCI. Based on the data collected, we have tried (1) to establish the behavior of MSCs after transplantation in SCI with an evaluation of cell survival, migration potential, distribution in the area of injured and intact tissue and possible differentiation; (2) to determine the effects MSCs on neuronal microenvironment and correlate them with the efficacy of functional recovery in SCI; (3) to ascertain the conditions under which MSCs demonstrate their best survival and greatest efficacy.

5 March 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
LGLuisa R. Galieva
Luisa R. Galieva
VJVictoria James
Victoria James
Yana MukhamedshinaYana Mukhamedshina
Yana Mukhamedshina
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
The use of extracellular vesicles (EVs) as cell free therapy is a promising approach to stimulate tissue regeneration including that of the nervous system. EVs transfer bioactive proteins and lipids, RNA and microRNAs, which play a relevant role in EV-mediated intercellular communication. The immunomodulatory, anti-inflammatory, and neuroprotective effects of mesenchymal stem cells-derived EVs have been well studied, knowledge of this paracrine mechanism and the availability of these cells, positions mesenchymal stem cells as a potential source of EVs for cell free therapy for a variety of regenerative and nervous system disorders. In this review, we focus on the immunomodulatory and neuroprotective effects of stem cells-derived EVs within in vitro and in vivo models of nerve disorders.

31 October 2020 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YCYurii A. Chelyshev
Yurii A. Chelyshev
IKIlyas M. Kabdesh
Ilyas M. Kabdesh
Yana MukhamedshinaYana Mukhamedshina
Yana Mukhamedshina

31 October 2017 in Frontiers in Neurology
Verified
Journal Article
Open access
Yana MukhamedshinaYana Mukhamedshina
Yana Mukhamedshina
EAElvira Akhmetzyanova
Elvira Akhmetzyanova
EMEkaterina V. Martynova
Ekaterina V. Martynova
Svetlana KhaiboullinaSvetlana Khaiboullina
Svetlana Khaiboullina
LGLuisa R. Galieva
Luisa R. Galieva
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Changes of the cytokine profile in blood serum and in the area of traumatic spinal cord injury (SCI) in rats were dealt with in this article. Our study has shown that an inflammatory reaction and immunological response are not limited within the CNS after SCI, but widespread. This fact was confirmed by changes detected in a cytokine profile in blood serum samples (MIP-1α, IL-1α, IL 2, IL-5, IL-1β, MCP-1, RANTES). There were also changes in the levels of MIP-1α, IL-1α, IL-2, IL-5, IL-18, GM-CSF, IL-17α, IFN-γ, IL-10, IL 13, MCP-1, GRO KC CINC-1 in samples of the rat injured spinal cord. The results underscore the complex cytokine network imbalance exhibited by SCI and show significant changes in concentrations of 14 cytokines/chemokines with different inflammatory and immunological activities.